The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 10, 2026 | Averill Julianne | Director | Grant(A) | 174K | — | $0 |
| Jun 10, 2026 | Faust Elizabeth | Director | Grant(A) | 196K | — | $0 |
| Jun 10, 2026 | Ray Sumita | Director | Grant(A) | 196K | — | $0 |
| Jun 10, 2026 | Aguiar Eric | Director | Grant(A) | 196K | — | $0 |
| Apr 1, 2026 | Hitchcock Michael J.M. | Interim CEO, Director | Grant(A) | 667K | — | $0 |
| Apr 1, 2026 | Erdtmann Rainer M | See Remarks, Director | Grant(A) | 453K | — | $0 |
| Dec 11, 2025 | Erdtmann Rainer M | See Remarks, Director | Buy(P) | 30K | $1.43 | $43K |
| Dec 2, 2025 | Hitchcock Michael J.M. | Interim CEO, Director | Buy(P) | 100K | $0.99 | $99K |
| Dec 1, 2025 | Erdtmann Rainer M | See Remarks, Director | Buy(P) | 10K | $1.05 | $11K |
| Nov 28, 2025 | Erdtmann Rainer M | See Remarks, Director | Buy(P) | 40K | $1.10 | $44K |
| Aug 11, 2025 | Erdtmann Rainer M | See Remarks, Director | Grant(A) | 1.2M | — | $0 |
| Aug 11, 2025 | Hitchcock Michael J.M. | Interim CEO, Director | Grant(A) | 916K | — | $0 |
| Jul 22, 2025 | Averill Julianne | Director | Grant(A) | 241K | — | $0 |
| Jun 11, 2025 | Chen Bihua | Director, 10% Owner | Grant(A) | 92K | — | $0 |
| Jun 11, 2025 | Ray Sumita | Director | Grant(A) | 92K | — | $0 |
| Jun 11, 2025 | Aguiar Eric | Director | Grant(A) | 92K | — | $0 |
| Jun 11, 2025 | Faust Elizabeth | Director | Grant(A) | 92K | — | $0 |
| Mar 26, 2025 | Hitchcock Michael J.M. | Interim CEO, Director | Grant(A) | 350K | — | $0 |
| Jan 31, 2025 | Erdtmann Rainer M | See Remarks, Director | Gift(G) | 10K | — | $0 |
| Jan 31, 2025 | Erdtmann Rainer M | See Remarks, Director | Gift(G) | 10K | — | $0 |
| Jan 31, 2025 | Erdtmann Rainer M | See Remarks, Director | Gift(G) | 10K | — | $0 |
| Jan 31, 2025 | Erdtmann Rainer M | See Remarks, Director | Gift(G) | 10K | — | $0 |
| Jan 31, 2025 | Erdtmann Rainer M | See Remarks, Director | Gift(G) | 10K | — | $0 |
| Jan 31, 2025 | Erdtmann Rainer M | See Remarks, Director | Gift(G) | 10K | — | $0 |
| Jan 28, 2025 | Erdtmann Rainer M | See Remarks, Director | Gift(G) | 40K | — | $0 |
| Nov 30, 2024 | Valle Franco | Chief Financial Officer | Grant(A) | 495 | $6.15 | $3K |
| Sep 30, 2024 | Hitchcock Michael J.M. | Director | Buy(P) | 10K | $10.06 | $101K |
| Jun 12, 2024 | Cormorant Global Healthcare Master Fund, LP | 10% Owner | Grant(A) | 51K | — | $0 |
| Jun 12, 2024 | Aguiar Eric | Director | Grant(A) | 51K | — | $0 |
| Jun 12, 2024 | Hitchcock Michael J.M. | Director | Grant(A) | 51K | — | $0 |
| Jun 12, 2024 | Faust Elizabeth | Director | Grant(A) | 51K | — | $0 |
| Jun 12, 2024 | Ray Sumita | Director | Grant(A) | 51K | — | $0 |
| Jun 11, 2024 | Valle Franco | Chief Financial Officer | Buy(P) | 13K | $4.43 | $55K |
| May 31, 2024 | Frias Juan Pablo | Chief Medical Officer | Grant(A) | 349 | $8.94 | $3K |
| May 31, 2024 | Valle Franco | Chief Financial Officer | Grant(A) | 4K | $3.78 | $17K |
| Jan 17, 2024 | Frias Juan Pablo | Chief Medical Officer | Grant(A) | 111K | — | $0 |
| Jan 17, 2024 | Erdtmann Rainer M | President and COO, Director | Grant(A) | 136K | — | $0 |
| Jan 17, 2024 | Valle Franco | Chief Financial Officer | Grant(A) | 145K | — | $0 |
| Jan 17, 2024 | Butler Thomas Andrew | Chief Executive Officer, Director, 10% Owner | Grant(A) | 408K | — | $0 |
| Dec 29, 2023 | Erdtmann Rainer M | President and COO, Director | Gift(G) | 3K | — | $0 |
| Dec 29, 2023 | Erdtmann Rainer M | President and COO, Director | Gift(G) | 3K | — | $0 |
| Dec 29, 2023 | Erdtmann Rainer M | President and COO, Director | Gift(G) | 12K | — | $0 |
| Dec 29, 2023 | Erdtmann Rainer M | President and COO, Director | Gift(G) | 3K | — | $0 |
| Dec 29, 2023 | Erdtmann Rainer M | President and COO, Director | Gift(G) | 3K | — | $0 |
| Dec 29, 2023 | Erdtmann Rainer M | President and COO, Director | Gift(G) | 3K | — | $0 |
| Dec 29, 2023 | Erdtmann Rainer M | President and COO, Director | Gift(G) | 3K | — | $0 |
| Nov 30, 2023 | Valle Franco | Chief Financial Officer | Grant(A) | 1K | $3.78 | $5K |
| Aug 31, 2023 | Frias Juan Pablo | Chief Medical Officer | Grant(A) | 300K | — | $0 |
| Jun 14, 2023 | Chen Bihua | Director, 10% Owner | Grant(A) | 7K | — | $0 |
| Jun 14, 2023 | Aguiar Eric | Director | Grant(A) | 7K | — | $0 |
| Jun 14, 2023 | Ray Sumita | Director | Grant(A) | 7K | — | $0 |
| Jun 14, 2023 | Faust Elizabeth | Director | Grant(A) | 7K | — | $0 |
| Jun 14, 2023 | Hitchcock Michael J.M. | Director | Grant(A) | 7K | — | $0 |
| Jun 1, 2023 | A2A Pharmaceuticals, Inc. | 10% Owner | Sell(S) | 50K | $34.56 | $1.7M |
| May 31, 2023 | Valle Franco | Chief Financial Officer | Grant(A) | 4K | $3.78 | $16K |
| May 31, 2023 | A2A Pharmaceuticals, Inc. | 10% Owner | Sell(S) | 75K | $33.81 | $2.5M |
| May 12, 2023 | A2A Pharmaceuticals, Inc. | 10% Owner | Sell(S) | 25K | $33.84 | $846K |
| May 9, 2023 | A2A Pharmaceuticals, Inc. | 10% Owner | Sell(S) | 150K | $34.50 | $5.2M |
| May 8, 2023 | A2A Pharmaceuticals, Inc. | 10% Owner | Sell(S) | 100K | $33.99 | $3.4M |
| Apr 20, 2023 | A2A Pharmaceuticals, Inc. | 10% Owner | Sell(S) | 200K | $29.12 | $5.8M |
| Mar 31, 2023 | A2A Pharmaceuticals, Inc. | 10% Owner | Buy(S) | 200K | $31.25 | $6.3M |
| Mar 31, 2023 | A2A Pharmaceuticals, Inc. | 10% Owner | Sell(S) | 200K | $31.25 | $6.3M |
| Mar 30, 2023 | Cormorant Global Healthcare Master Fund, LP | 10% Owner | Buy(P) | 400K | $30.00 | $12.0M |
| Jan 6, 2023 | Butler Thomas Andrew | Chief Executive Officer, Director, 10% Owner | Grant(A) | 354K | — | $0 |
| Jan 6, 2023 | Valle Franco | Chief Financial Officer | Grant(A) | 126K | — | $0 |
| Jan 6, 2023 | Erdtmann Rainer M | President and COO, Director | Grant(A) | 118K | — | $0 |
| Nov 30, 2022 | Valle Franco | Chief Financial Officer | Grant(A) | 3K | $3.78 | $10K |
| Nov 14, 2022 | Hitchcock Michael J.M. | Director | Buy(P) | 5K | $7.93 | $40K |
| Nov 11, 2022 | Valle Franco | Chief Financial Officer | Buy(P) | 4K | $7.63 | $31K |
| Aug 16, 2022 | A2A Pharmaceuticals, Inc. | 10% Owner | Sell(P) | 31K | $13.87 | $426K |
| Jul 21, 2022 | A2A Pharmaceuticals, Inc. | 10% Owner | Sell(S) | 35K | $11.21 | $389K |
| Jun 24, 2022 | A2A Pharmaceuticals, Inc. | 10% Owner | Sell(S) | 35K | $11.76 | $408K |
| Jun 22, 2022 | Cormorant Asset Management, LP | 10% Owner | Grant(A) | 24K | — | $0 |
| Jun 22, 2022 | Faust Elizabeth | Director | Grant(A) | 46K | — | $0 |
| Jun 22, 2022 | Aguiar Eric | Director | Grant(A) | 24K | — | $0 |
| Jun 22, 2022 | Hitchcock Michael J.M. | Director | Grant(A) | 24K | — | $0 |
| Jun 22, 2022 | Ray Sumita | Director | Grant(A) | 24K | — | $0 |
| Jun 1, 2022 | Biomea Health, LLC | 10% Owner | Other(J) | 4.4M | — | $0 |
| May 31, 2022 | Valle Franco | Chief Financial Officer | Grant(A) | 3K | $4.67 | $15K |
| Mar 3, 2022 | Ray Sumita | Director | Grant(A) | 21K | — | $0 |
| Jan 14, 2022 | Valle Franco | Chief Financial Officer | Buy(P) | 10K | $8.68 | $87K |
| Dec 4, 2021 | Butler Thomas Andrew | CEO, Director, 10% Owner | Grant(A) | 305K | — | $0 |
| Dec 4, 2021 | Erdtmann Rainer M | President & COO, Director, 10% Owner | Grant(A) | 165K | — | $0 |
| Dec 4, 2021 | Valle Franco | Chief Financial Officer | Grant(A) | 145K | — | $0 |
| Sep 17, 2021 | A2A Pharmaceuticals, Inc. | 10% Owner | Buy(P) | 35K | $10.96 | $380K |
| Sep 17, 2021 | Stergiopoulos Sotirios | Director | Buy(P) | 35K | $10.96 | $380K |
| Aug 23, 2021 | Erdtmann Rainer M | President & COO, Director, 10% Owner | Buy(P) | 24K | $13.20 | $317K |
| Aug 23, 2021 | Butler Thomas Andrew | CEO, Director, 10% Owner | Buy(P) | 24K | $13.20 | $317K |
| Aug 18, 2021 | Butler Thomas Andrew | CEO, Director, 10% Owner | Buy(P) | 14K | $10.77 | $151K |
| Aug 17, 2021 | Butler Thomas Andrew | CEO, Director, 10% Owner | Buy(P) | 14K | $10.79 | $151K |
| Aug 3, 2021 | Valle Franco | Chief Financial Officer | Grant(A) | 165K | — | $0 |
| Apr 15, 2021 | Aguiar Eric | Director | Grant(A) | 29K | — | $0 |
| Apr 15, 2021 | Stergiopoulos Sotirios | Director | Grant(A) | 29K | — | $0 |
| Apr 15, 2021 | Hitchcock Michael J.M. | Director | Grant(A) | 29K | — | $0 |
| Apr 15, 2021 | Butler Thomas Andrew | CEO, Director, 10% Owner | Buy(P) | 176K | $17.00 | $3.0M |
| Apr 15, 2021 | Erdtmann Rainer M | President and COO, Director, 10% Owner | Buy(P) | 2K | $17.00 | $41K |
| Apr 15, 2021 | Erdtmann Rainer M | President and COO, Director, 10% Owner | Buy(P) | 3K | $17.00 | $51K |
| Apr 15, 2021 | Erdtmann Rainer M | President and COO, Director, 10% Owner | Buy(P) | 3K | $17.00 | $51K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).